Advertisement
UK markets close in 2 hours 35 minutes
  • FTSE 100

    8,083.83
    +39.02 (+0.49%)
     
  • FTSE 250

    19,796.31
    -3.41 (-0.02%)
     
  • AIM

    754.93
    +0.06 (+0.01%)
     
  • GBP/EUR

    1.1639
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2439
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    53,419.02
    +347.04 (+0.65%)
     
  • CMC Crypto 200

    1,438.23
    +14.13 (+0.99%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.11
    -0.25 (-0.30%)
     
  • GOLD FUTURES

    2,332.80
    -9.30 (-0.40%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,163.79
    +26.14 (+0.14%)
     
  • CAC 40

    8,143.18
    +37.40 (+0.46%)
     

Scientist Entrepreneurs - Scaling Breakout Engineering Biology Companies

Biology as technology will re-invent trillion dollar industries and enhance human and planetary evolution. In this session, two early-stage investors and company builders, Arvind Gupta and Ursheet Parikh, will be in conversation with a leading author and seed investor Po Bronson, Managing Director of IndieBio. They will share their playbook on scaling start-ups touching upon three seminal areas which influence trajectory – fundraising, hiring, and product design. Their insights will draw on their experience with companies including ingredients-as-service leader Geltor which raised a $91 million Series B in 2020, CRISPR platform Mammoth Biosciences whose dream team includes co-founder Nobel Laureate Jennifer Doudna, and Endpoint Health, started by the founding team of GeneWEAVE (acquired by Roche) and former YC Bio Partner Diego Rey, which is designing a new class of therapeutic products that focus on hospital conditions that kill as many people as cancer.